Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Pfizer Inc
  6. News
  7. Summary
       

PFIZER INC
End-of-day quote Nyse  -  10:00:49 2023-03-22 am EDT
- USD    0.00%
03:36aChina approves its first mRNA vaccine, from domestic drugmaker CSPC
RE
03/21US declines to force lower price on cancer drug Xtandi
RE
03/21U.S. FDA to soon decide on second round of Omicron-tailored boosters - WSJ
RE
SummaryNewsRatingsCalendarCompanyFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about PFIZER INC
03/21Pfizer Invites Public to View and Listen to Webcast of May 2 Conference Call with Analy..
BU
03/17Wells Fargo Adjusts Price Target on Pfizer to $44 From $50, Maintains Equal-Weight Rati..
MT
03/17FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer's ..
AQ
03/17Pfizer, Astellas Pharma Say Prostate Cancer Phase 3 Trial Meets Primary Endpoint
MT
03/17Pfizer's COVID-19 Drug Secures US FDA Panel Backing for Full Approval
MT
03/16Pfizer Inc. and Astellas Pharma Inc. Announce Positive Topline Results from Phase 3 EMB..
CI
03/16Advisory panel recommends full FDA approval for COVID-19 medication Paxlovid
AQ
03/1619 pill Paxlovid moves closer to full FDA approval
AQ
03/1619 pill Paxlovid moves closer to full FDA approval
AQ
03/16Pfizer's PAXLOVID COVID-19 Treatment Gets Approval From US FDA's Advisory Panel
MT
03/16Pfizer's PAXLOVID Wins FDA Advisory Panel Approval
MT
03/16FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer's ..
BU
03/16Pfizer's Paxlovid Reportedly Gets FDA Panel Backing for Full Approval
MT
03/16Pfizer to Replace Migraine-Drug Packaging Over Child-Safety Issues -- Update
DJ
03/16Pfizer Recalls Migraine Drug Due to Packaging Flaw
MT
More most relevant news
All news about PFIZER INC
03:36aChina approves its first mRNA vaccine, from domestic drugmaker CSPC
RE
03/21US declines to force lower price on cancer drug Xtandi
RE
03/21U.S. FDA to soon decide on second round of Omicron-tailored boosters - WSJ
RE
03/21Pfizer Invites Public to View and Listen to Webcast of May 2 Conference Call with Analy..
BU
03/21Mainz Biomed ($MYNZ) Inks Accretive Partnership To Expand Marketing Reach Of ColoAlert..
AQ
03/20Moderna expects to price its COVID vaccine at about $130 in the US
RE
03/20Astellas, Pfizer Log Positive Topline Results from Prostrate Cancer Drug Trial
MT
03/17The Week in Numbers: banking on a bailout
RE
03/17The Week in Numbers: banking on a bailout
RE
03/17Wells Fargo Adjusts Price Target on Pfizer to $44 From $50, Maintains Equal-Weight Rati..
MT
More news
News in other languages on PFIZER INC
03:36aLa Chine approuve son premier vaccin à ARNm, produit par le fabricant national CSPC
03/21La FDA américaine se prononcera bientôt sur la deuxième série de stimulants Omicron - W..
03/21Moderna: le prix du vaccin anti Covid devrait être de 130 dollars par dose
03/17Humanwell Healthcare obtient le feu vert pour tester un anticonvulsivant dans le traite..
03/17Pfizer : données positives pour le Xtandi
03/17Pfizer : Vote positif de la FDA pour le PAXVOLID
03/17Pfizer et Astellas Pharma annoncent que l'essai de phase 3 sur le cancer de la prostate..
03/17Le médicament COVID-19 de Pfizer décroche le soutien du groupe d'experts de la FDA amér..
03/16Pfizer Inc. et Astellas Pharma Inc. annoncent les premiers résultats positifs de l'essa..
03/16Asesores de la FDA respaldan plena aprobación del tratamiento para el COVID de Pfizer
More news
Analyst Recommendations on PFIZER INC
03/17Wells Fargo Adjusts Price Target on Pfizer to $44 From $50, Maintains Equal-Weight Rati..
MT
03/14PFIZER INC : UBS reiterates its Neutral rating
MD
03/06Jefferies Starts Pfizer at Hold With $43 Price Target
MT
03/06Analyst recommendations: Eli Lilly, Haleon, KB Home, Merck, Pfiz..
MS
03/06PFIZER INC : Jefferies remains Neutral
MD
More recommendations
Press releases
03/21Pfizer Invites Public to View and Listen to Webcast of May 2 Conference Call with Analy..
BU
03/21Mainz Biomed ($MYNZ) Inks Accretive Partnership To Expand Marketing Reach Of ColoAlert..
AQ
03/17FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer's ..
AQ
03/16Advisory panel recommends full FDA approval for COVID-19 medication Paxlovid
AQ
03/1619 pill Paxlovid moves closer to full FDA approval
AQ
More press releases
Upcoming event on PFIZER INC
04/27/23Annual General Meeting
Upcoming sector events
04/18/23JOHNSON & JOHNSON : Q1 2023 Earnings Release
04/27/23ABBVIE INC. : Q1 2023 Earnings Release (Projected)
04/27/23ELI LILLY AND COMPANY : Q1 2023 Earnings Release
04/27/23MERCK & CO., INC. : Q1 2023 Earnings Release
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration
fermer